Los puntos clave no están disponibles para este artículo en este momento.
The SMILe-ICM appears to offer survival and rehospitalization benefits, particularly for vulnerable groups, e.g., patients living alone. Larger, adequately powered studies are needed to validate these findings.
Leppla et al. (Tue,) studied this question.